ABBV vs AMD: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Advanced Micro Devices, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-06.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
Advanced Micro Devices, Inc. · Technology
$555.79
+24.0% upside to fair value
Grade B
QuantHub Verdict
AMD has more upside to fair value
(+24.0%).
ABBV trades at a lower forward P/E
(128.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
AMD |
| Current Price |
$261.07 |
$555.79 |
| Fair Value Estimate |
$264.30 |
$689.29 |
| Upside to Fair Value |
+1.2%
|
+24.0%
|
| Market Cap |
$461.3B |
$906.3B |
| Forward P/E |
128.0x
|
177.7x
|
| EV / EBITDA |
31.0x
|
110.2x
|
| Price / Sales |
7.3x
|
24.1x
|
| Price / FCF |
22.1x
|
105.3x
|
| Revenue Growth YoY |
+12.4%
|
+37.8%
|
| Gross Margin |
70.7%
|
50.3%
|
| Operating Margin |
27.6%
|
11.7%
|
| Return on Equity |
68.0%
|
8.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.52%
|
0.95%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
Advanced Micro Devices, Inc. (AMD) is a leading semiconductor company specializing in high-performance CPUs and GPUs with a competitive moat driven by technical innovation and ecosystem scale. Under CEO Dr. Lisa Su's leadership since 2014, AMD has transformed from a $2 billion market cap to over $90 billion, gaining significant market share from Intel and Nvidia. The company reported $34.6 billio…
Accumulation Zones
| Metric |
ABBV |
AMD |
| Zone Low |
$198.23 |
$516.97 |
| Zone High |
$224.66 |
$585.90 |
| In Buy Zone? |
No
|
Yes
|